PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scripps Florida scientists find regulator of amyloid plaque buildup in Alzheimer's disease

2014-01-23
(Press-News.org) Contact information: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute
Scripps Florida scientists find regulator of amyloid plaque buildup in Alzheimer's disease

JUPITER, FL – January 23, 2014 – Scientists from the Florida campus of The Scripps Research Institute have identified a critical regulator of a molecule deeply involved in the progression of Alzheimer's disease.

The new study, published in an advance, online edition of the Journal of Biological Chemistry, shows for the first time that levels of this regulating protein are decreased in the brains of Alzheimer's disease sufferers and that this decrease could be a significant factor in the advance of the disease.

The regulator is known as Rheb, a protein that many believe may be active in neural plasticity, the ability of the brain to change in response to learning.

In the new study, the scientists found that Rheb binds and regulates activity of a molecule known as BACE1, an important enzyme in Alzheimer's disease pathology, establishing for the first time a new molecular link between Rheb and BACE1.

"We found that Rheb regulates BACE1, which is a major drug target in Alzheimer's disease," said Srini Subramaniam, a TSRI biologist who led the study. "Studies of the autopsied brains of Alzheimer's patients have found a significant reduction in Rheb, so it is possible that an increase in Rheb could reverse the buildup of amyloid plaque."

The study noted that in some genetically modified animal models, an increase of Rheb has already been shown to reduce BACE1 levels and the production of amyloid plaque.

"If we can uncover the mechanism by which Rheb alters BACE1 levels, that would be a very good drug target," said Neelam Shahani, a first author of the study with William Pryor, both research associates in the Subramaniam lab.

The new study indicates that Rheb degrades BACE1 through a number of pathways, but more research needs to be done before drug candidates can be developed.

"We're very interested in the disease process and plan to keep moving forward to understand precisely how Rheb regulates BACE1," said Pryor.

INFORMATION:

In addition to Subramaniam, Shahani and Pryor, other authors of the study, "Rheb GTPase Regulates β-Secretase Levels and Amyloid β Generation," include Supriya Swarnkar of TSRI; Nikolai Kholodilov and Robert E Burke of Columbia University; and Gopal Thinakaran of The University of Chicago. For more information, see http://www.jbc.org/content/early/2013/12/24/jbc.M113.532713.

This work was supported by the O'Keeffe Neuroscience Scholar Award and by the State of Florida.



ELSE PRESS RELEASES FROM THIS DATE:

Physical activity significantly extends lives of cancer survivors

2014-01-23
MAYWOOD, Il. – Physical activity significantly extends the lives of male cancer survivors, a new study of 1,021 men has found. During the period while the ...

NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer

2014-01-23
Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized ...

A new wrinkle in the control of waves

2014-01-23
CAMBRIDGE, Mass-- Flexible, layered materials textured with nanoscale wrinkles could provide a new way of controlling the wavelengths and distribution ...

Analysis indicates that North and tropical Atlantic warming affects Antarctic climate

2014-01-23
The gradual warming of the North and tropical Atlantic Ocean is contributing to climate change in Antarctica, a team of ...

Salmonella infection mitigates asthma

2014-01-23
Researchers from Germany have identified the mechanism by which Salmonella infections can reduce the incidence of asthma in mice. The research, which appears ahead of print in the journal ...

Palau's coral reefs surprisingly resistant to ocean acidification

2014-01-23
Marine scientists working on the coral reefs of Palau have made two unexpected discoveries that could provide insight ...

More benefits emerging for one type of omega-3 fatty acid: DHA

2014-01-23
CORVALLIS, Ore. – A study of the metabolic effects of omega-3 fatty acids, especially DHA, concludes that these compounds may have an even wider range of biological impacts than previously considered, ...

UGA researchers discover origin of unusual glands in the body

2014-01-23
Athens, Ga. – The thymus gland is a critical component of the human immune system that is responsible for the development of T-lymphocytes, or T-cells, which help organize and lead the body's fighting forces ...

Morbidity higher in obese liver transplant recipients with diabetes

2014-01-23
Researchers from New Zealand report that morbidity following liver transplant is highest among obese patients with diabetes, but these risk factors do not influence post-transplant survival. ...

Major South African trial did not improve tuberculosis control in gold mines

2014-01-23
PUBLIC RELEASE DATE: 22-Jan-2014 [ | E-mail ] var addthis_pub="eurekalert"; var addthis_options = "favorites, delicious, digg, facebook, twitter, google, newsvine, reddit, slashdot, stumbleupon, buzz, more" Share Contact: Katie Steels press@lshtm.ac.uk 44-020-792-92802 London School of Hygiene & Tropical Medicine Major South African trial did not improve tuberculosis control in gold mines AUDIO: Professor Alison Grant of the London School of Hygiene & Tropical Medicine ...

LAST 30 PRESS RELEASES:

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

2026 Hertz Fellowship Application Now Open

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

[Press-News.org] Scripps Florida scientists find regulator of amyloid plaque buildup in Alzheimer's disease